Recent Quarter Total Invested
$373.37 M
Recent Quarter Institutional Ownership Percentage
84.78%
Total Invested of Last Quarter
$536.33 M
Ownership Percentage of Last Quarter
100.82%
iTeos Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 3.88 M | $39.64 M | 100.00% | 9.00% |
| RA CAPITAL MANAGEMENT, L.P. | 11/14/2024 | 3.18 M | $32.52 M | -9.45% | 7.38% |
| BOXER CAPITAL, LLC | 11/14/2024 | 2.95 M | $30.09 M | 0.00% | 6.83% |
| MPM ASSET MANAGEMENT LLC | 11/13/2024 | 2.74 M | $27.96 M | 0.00% | 6.35% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2024 | 2.41 M | $24.58 M | 100.00% | 5.58% |
| BIOIMPACT CAPITAL LLC | 11/13/2024 | 1.75 M | $17.83 M | 0.00% | 4.05% |
| ECOR1 CAPITAL, LLC | 11/14/2024 | 1.61 M | $16.42 M | -50.50% | 3.73% |
| 683 CAPITAL MANAGEMENT, LLC | 11/14/2024 | 1.57 M | $16.03 M | 40.83% | 3.64% |
| CITADEL ADVISORS LLC | 11/14/2024 | 1.24 M | $12.62 M | 77.28% | 2.87% |
| STATE STREET CORP | 11/14/2024 | 1.18 M | $12.00 M | 21.94% | 2.72% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 1.05 M | $10.68 M | 15.18% | 2.43% |
| VESTAL POINT CAPITAL, LP | 11/14/2024 | 1.03 M | $10.47 M | -41.43% | 2.38% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 913,013 | $9.32 M | 24.68% | 2.12% |
| CANDRIAM S.C.A. | 11/13/2024 | 769,213 | $7.85 M | 51.03% | 1.78% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 640,350 | $6.54 M | 3.24% | 1.48% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 536,400 | $5.48 M | -4.15% | 1.24% |
| K2 PRINCIPAL FUND, L.P. | 11/15/2024 | 534,951 | $5.46 M | 108.09% | 1.24% |
| MORGAN STANLEY | 11/14/2024 | 501,366 | $5.12 M | -53.97% | 1.16% |
| JPMORGAN CHASE & CO | 11/08/2024 | 467,319 | $4.77 M | 1.16% | 1.08% |
| K2 PRINCIPAL FUND, L.P. | 11/15/2024 | 403,700 | $4.12 M | -10.29% | 0.94% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2024 | 376,737 | $3.85 M | 527.90% | 0.87% |
| CAPTION MANAGEMENT, LLC | 11/14/2024 | 302,200 | $3.09 M | 100.00% | 0.70% |
| ALGERT GLOBAL LLC | 11/12/2024 | 256,139 | $2.62 M | 92.00% | 0.59% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 222,135 | $2.27 M | 3.93% | 0.52% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 11/14/2024 | 205,863 | $2.10 M | 16.76% | 0.48% |
| CAPTION MANAGEMENT, LLC | 11/14/2024 | 200,000 | $2.04 M | 100.00% | 0.46% |
| SATURN V CAPITAL MANAGEMENT LLC | 11/14/2024 | 195,704 | $2.00 M | -46.74% | 0.45% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 175,591 | $1.79 M | 354.85% | 0.41% |
| READYSTATE ASSET MANAGEMENT LP | 11/14/2024 | 169,819 | $1.73 M | 97.19% | 0.39% |
| CLEARLINE CAPITAL LP | 11/14/2024 | 167,417 | $1.71 B | 6.71% | 0.39% |
| DAFNA CAPITAL MANAGEMENT LLC | 11/14/2024 | 161,584 | $1.65 M | 11.93% | 0.37% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 157,331 | $1.61 M | -56.07% | 0.36% |
| KENNEDY CAPITAL MANAGEMENT LLC | 11/14/2024 | 155,435 | $1.59 M | 3.45% | 0.36% |
| EAGLE ASSET MANAGEMENT INC | 11/12/2024 | 151,649 | $1.41 M | -7.66% | 0.35% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 11/14/2024 | 132,364 | $1.35 M | 100.00% | 0.31% |
| CITADEL ADVISORS LLC | 11/14/2024 | 129,500 | $1.32 M | 118.38% | 0.30% |
| D. E. SHAW & CO., INC. | 11/14/2024 | 125,761 | $1.28 M | -42.66% | 0.29% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 122,697 | $1.25 M | 40.03% | 0.28% |
| BARCLAYS PLC | 11/19/2024 | 113,211 | $1.16 M | -7.41% | 0.26% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 105,769 | $1.08 M | 20.86% | 0.25% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 105,500 | $1.08 M | -40.90% | 0.24% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 103,165 | $1.05 M | -14.92% | 0.24% |
| VICTORY CAPITAL MANAGEMENT INC | 11/05/2024 | 95,240 | $972,400 | -13.72% | 0.22% |
| INVESCO LTD. | 11/12/2024 | 84,355 | $861,265 | -0.27% | 0.20% |
| IKARIAN CAPITAL, LLC | 11/14/2024 | 78,574 | $802,241 | 0.00% | 0.18% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 76,766 | $783,780 | -8.65% | 0.18% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2024 | 68,243 | $696,760 | 100.00% | 0.16% |
| PANAGORA ASSET MANAGEMENT INC | 11/13/2024 | 67,723 | $691,452 | -48.52% | 0.16% |
| UBS OCONNOR LLC | 11/14/2024 | 65,940 | $673,247 | 86.68% | 0.15% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 65,767 | $671,481 | 5.37% | 0.15% |
iTeos Therapeutics, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of ITOS shares?
During the previous two years, 163 institutional investors and hedge funds held shares of iTeos Therapeutics, Inc.. The most heavily invested institutionals were:
BlackRock Funding, Inc. /DE: 3.88 M
RA CAPITAL MANAGEMENT, L.P.: 3.18 M
Boxer Capital, LLC: 2.95 M
MPM ASSET MANAGEMENT LLC: 2.74 M
TANG CAPITAL MANAGEMENT LLC: 2.41 M
BioImpact Capital LLC: 1.75 M
-
What percentage of iTeos Therapeutics, Inc. stock is owned by institutional investors?
84.78% of iTeos Therapeutics, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at ITOS ?
Institutional investors have bought a total of 38.50 M shares in the last 24 months. This purchase volume represents approximately $320.67 M in transactions.